Genomic Health Inc (GHDX)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-MEDICAL LABORATORIES

301 PENOBSCOT DRIVE REDWOOD CITY, CA 94063

Focuses on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The company's principal product is the Oncotype DX genomic test. It also has a clinical development program including tests to predict responsiveness to specific chemotherapies.

View SEC Filings from GHDX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GHDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GHDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COHEN FRED E

  • Director
0 2019-11-08 0

GRAHAM GINGER L

  • Director
0 2019-11-08 0

COLE G BRADLEY CFO

  • Officer
0 2019-11-08 0

SHAK STEVEN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-11-08 0

POPOVITS KIMBERLY J PRESIDENT AND CEO

  • Officer
  • Director
0 2019-11-08 0

FUCHS HENRY J

  • Director
0 2019-11-08 0

MCEACHRON KIM CHIEF PEOPLE OFFICER

  • Officer
0 2019-11-08 0

LEBER LAURA CHIEF COMMUNICATION OFFICER

  • Officer
0 2019-11-08 0

VAUGHN JAMES J CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-11-08 0

PLA FREDERIC COO

  • Officer
0 2019-11-08 0

RADFORD JASON W. CHIEF LEGAL OFFICER

  • Officer
0 2019-11-08 0

PARKER GEOFFREY M.

  • Director
0 2019-11-08 0

FLANNELLY BARRY P

  • Director
0 2019-11-08 0

HOOF TORSTEN CHIEF INT'L COMMERCIAL OFFICER

  • Officer
0 2019-11-08 0

EXACT SCIENCES CORP

  • 10% Owner
  • SEE FOOTNOTES
100 2019-11-08 0

BAKER BROS. ADVISORS LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

BAKER BROS. INVESTMENTS, L.P.

BAKER/TISCH INVESTMENTS, LP

  • Director
  • 10% Owner
9,430,119 2019-10-01 0

BAKER BROS. ADVISORS LP

BAKER BROS. INVESTMENTS II, L.P.

BAKER BROS. INVESTMENTS, L.P.

BAKER/TISCH INVESTMENTS, LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
9,471,630 2019-08-29 0

BAKER BROS. ADVISORS LP

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

BAKER BROS. ADVISORS LP

BAKER BROS. INVESTMENTS II, L.P.

BAKER BROTHERS LIFE SCIENCES LP

BAKER BROS. INVESTMENTS, L.P.

BAKER FELIX

BAKER JULIAN

BAKER/TISCH INVESTMENTS, LP

BAKER BROS. INVESTMENTS II, L.P.

14159, L.P.

BAKER BROS. INVESTMENTS, L.P.

667, L.P.

BAKER/TISCH INVESTMENTS, LP

BAKER BROS. ADVISORS (GP) LLC

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
13,494,075 2018-11-16 0

FEBBO PHILLIP G. CHIEF MEDICAL OFFICER

  • Officer
21,387 2018-02-20 0

LIVINGSTON RANDALL S

  • Director
0 2016-06-10 0

COLELLA SAMUEL D

  • Director
59,653 2014-10-01 0

SCHORNO DEAN L CFO

  • Officer
30,673 2014-06-10 0

HIBBS KATHY L SVP & GENERAL COUNSEL

  • Officer
15,787 2014-02-15 0

MYERS WOODROW A JR

  • Director
3,880 2013-10-01 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER FELIX

BAKER BROS. INVESTMENTS, L.P.

BAKER BROS. INVESTMENTS II, L.P.

BAKER/TISCH INVESTMENTS, LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

BAKER BROS ADVISORS LLC

BAKER JULIAN

  • Director
  • 10% Owner
0 2013-06-07 0

BAKER FELIX

BAKER JULIAN

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

667, L.P.

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
26,888,819 2013-06-04 0

BAKER FELIX

BAKER BROS. INVESTMENTS, L.P.

BAKER BROS. INVESTMENTS II, L.P.

BAKER/TISCH INVESTMENTS, LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

  • Director
  • 10% Owner
12,537,654 2013-01-01 0

BAKER FELIX

  • Director
  • 10% Owner
11,377,773 2012-10-01 0

FBB ASSOCIATES

  • Director
173,897 2012-07-26 0

14159, L.P.

  • Director
247,063 2012-07-26 0

BAKER BROS. INVESTMENTS, L.P.

  • Director
173,897 2012-07-26 0

BAKER BROS. INVESTMENTS II, L.P.

  • Director
13,238 2012-07-26 0

BAKER/TISCH INVESTMENTS, LP

  • Director
194,161 2012-07-26 0

667, L.P.

  • Director
1,488,539 2012-07-26 0

BAKER BROTHERS LIFE SCIENCES LP

  • Director
9,086,690 2012-07-26 0

SCOTT RANDAL W CEO, INVITAE CORPORATION*

  • Officer
  • Director
1,200,881 2012-07-10 0

BAKER JULIAN

  • Director
0 2012-06-08 0

BAKER JULIAN

BAKER BROS ADVISORS LLC

BAKER FELIX

  • Director
  • 10% Owner
20,693,832 2012-05-21 0

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
0 2012-04-12 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
8,255,421 2012-03-07 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
227,840 2012-03-07 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
1,484,977 2012-03-07 0

BAKER JOFFRE CHIEF SCIENTIFIC OFFICER

  • Officer
235,302 2012-02-15 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
187,135 2011-06-30 0

BYERS BROOK H

  • Director
24,357 2011-04-01 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
194,161 2009-05-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments